← Patent-cliff monitor small molecule DETECTNET COPPER CU-64 DOTATATE
Loss of exclusivity September 2041 latest FDA-listed patent expiry
Drug detail Brand name DETECTNET Active ingredient COPPER CU-64 DOTATATE Strength 4mL (1mCi/ML) Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval September 2020 Marketing status RX
Listed patents Patent Expires Type 12102696 September 2041 product 10383961 July 2033 use U-2951 10159759 August 2032 use U-2951 11160888 August 2032 use U-2951
Regulatory exclusivity Code Expires ODE-317 September 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.